Charles Atkinson

Array ( [id] => 6304381 [patent_doc_number] => 20100068729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'METHOD AND KITS FOR THE DIAGNOSIS OF DIABETES' [patent_app_type] => utility [patent_app_number] => 12/556269 [patent_app_country] => US [patent_app_date] => 2009-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7774 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068729.pdf [firstpage_image] =>[orig_patent_app_number] => 12556269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8160111 [patent_doc_number] => 20120101034 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-04-26 [patent_title] => 'PROCESS FOR SOLUBILIZING GLUCAGON-LIKE PEPTIDE 1 COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/551841 [patent_app_country] => US [patent_app_date] => 2009-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7750 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0101/20120101034.pdf [firstpage_image] =>[orig_patent_app_number] => 12551841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8160111 [patent_doc_number] => 20120101034 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-04-26 [patent_title] => 'PROCESS FOR SOLUBILIZING GLUCAGON-LIKE PEPTIDE 1 COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/551841 [patent_app_country] => US [patent_app_date] => 2009-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7750 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0101/20120101034.pdf [firstpage_image] =>[orig_patent_app_number] => 12551841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6220003 [patent_doc_number] => 20100055098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'METHOD FOR TREATING MULTIPLE SCLEROSIS PATIENTS WITH ANTI-IL2R ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/549501 [patent_app_country] => US [patent_app_date] => 2009-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12595 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055098.pdf [firstpage_image] =>[orig_patent_app_number] => 12549501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6527031 [patent_doc_number] => 20100015062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Method of treating pulmonary disease with interferons' [patent_app_type] => utility [patent_app_number] => 12/460376 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21521 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015062.pdf [firstpage_image] =>[orig_patent_app_number] => 12460376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7740044 [patent_doc_number] => 08105789 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'Diagnosis and treatment of infectious diseases through indel-differentiated proteins' [patent_app_type] => utility [patent_app_number] => 12/495536 [patent_app_country] => US [patent_app_date] => 2009-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 23682 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/105/08105789.pdf [firstpage_image] =>[orig_patent_app_number] => 12495536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6183926 [patent_doc_number] => 20110123542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'CCL20-SPECIFIC ANTIBODIES FOR CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 13/000991 [patent_app_country] => US [patent_app_date] => 2009-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15989 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20110123542.pdf [firstpage_image] =>[orig_patent_app_number] => 13000991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7566959 [patent_doc_number] => 20110287022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'INTERFERON ALPHA-INDUCED PHARMACODYNAMIC MARKERS' [patent_app_type] => utility [patent_app_number] => 12/999626 [patent_app_country] => US [patent_app_date] => 2009-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 127 [patent_figures_cnt] => 127 [patent_no_of_words] => 73722 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20110287022.pdf [firstpage_image] =>[orig_patent_app_number] => 12999626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6101627 [patent_doc_number] => 20110165119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'TELAPREVIR DOSING REGIMEN' [patent_app_type] => utility [patent_app_number] => 12/996650 [patent_app_country] => US [patent_app_date] => 2009-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2998 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165119.pdf [firstpage_image] =>[orig_patent_app_number] => 12996650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262166 [patent_doc_number] => 20100297063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'CYTOKINE ZALPHA11 LIGAND ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/469267 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 70880 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297063.pdf [firstpage_image] =>[orig_patent_app_number] => 12469267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4618754 [patent_doc_number] => 07998468 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Cytokine zalpha11 ligand antibodies' [patent_app_type] => utility [patent_app_number] => 12/469303 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 71188 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/998/07998468.pdf [firstpage_image] =>[orig_patent_app_number] => 12469303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4473352 [patent_doc_number] => 07867518 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-11 [patent_title] => 'Controlled release compositions for interferon based on PEGT/PBT block copolymers and method for preparation thereof' [patent_app_type] => utility [patent_app_number] => 12/466430 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13138 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/867/07867518.pdf [firstpage_image] =>[orig_patent_app_number] => 12466430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146892 [patent_doc_number] => 08163885 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Humanized antibodies against human interferon-alpha' [patent_app_type] => utility [patent_app_number] => 12/597357 [patent_app_country] => US [patent_app_date] => 2009-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 31201 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163885.pdf [firstpage_image] =>[orig_patent_app_number] => 12597357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5484931 [patent_doc_number] => 20090274696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'METHODS FOR TREATING INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 12/432617 [patent_app_country] => US [patent_app_date] => 2009-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 26727 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20090274696.pdf [firstpage_image] =>[orig_patent_app_number] => 12432617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4461475 [patent_doc_number] => 07879978 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Macaca fascicularis ST2L' [patent_app_type] => utility [patent_app_number] => 12/415095 [patent_app_country] => US [patent_app_date] => 2009-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5818 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879978.pdf [firstpage_image] =>[orig_patent_app_number] => 12415095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7499257 [patent_doc_number] => 20110262386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'METHODS OF TREATING INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 12/918964 [patent_app_country] => US [patent_app_date] => 2009-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 31496 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262386.pdf [firstpage_image] =>[orig_patent_app_number] => 12918964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070138 [patent_doc_number] => 20110044988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'METHODS OF TREATMENT USING ANTI-MIF ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/918968 [patent_app_country] => US [patent_app_date] => 2009-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 33316 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20110044988.pdf [firstpage_image] =>[orig_patent_app_number] => 12918968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552972 [patent_doc_number] => 20090286958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'INTERFERON-BETA FUSION PROTEINS AND USES' [patent_app_type] => utility [patent_app_number] => 12/406387 [patent_app_country] => US [patent_app_date] => 2009-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 21395 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286958.pdf [firstpage_image] =>[orig_patent_app_number] => 12406387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 211200 [patent_doc_number] => 07622106 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-11-24 [patent_title] => 'Necrosis assay' [patent_app_type] => utility [patent_app_number] => 12/399872 [patent_app_country] => US [patent_app_date] => 2009-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7910 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/622/07622106.pdf [firstpage_image] =>[orig_patent_app_number] => 12399872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5571625 [patent_doc_number] => 20090255004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'G-Protein Coupled Receptor and Uses Therefor' [patent_app_type] => utility [patent_app_number] => 12/397761 [patent_app_country] => US [patent_app_date] => 2009-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 33337 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20090255004.pdf [firstpage_image] =>[orig_patent_app_number] => 12397761 [rel_patent_id] =>[rel_patent_doc_number] =>)